Why is Avidity Biosciences (RNA) a Battleground Stock with Massive Short Interest

Related Articles

Why is Intellia Therapeutics (NTLA) a Battleground Stock with 38% Short Interest

6 months ago

What Does High Short Interest Really Mean for a Stock

6 months ago

Why is CleanSpark Attracting Such High Short Interest

6 months ago

Why is Kaixin Holdings (KXIN) Facing Such Extreme Short Interest

6 months ago

Category

You may also like

Stock News•1 months ago

Wall Street Analysts Predict a 140.06% Upside in Silence Therapeutics (SLN): Here's What You Should Know

Silence Therapeutics (SLN) could see a 140.1% upside based on the average Wall Street price target, supported by a positive trend in earnings estimate revisions. The stock's near-term path may hinge o...

SLN

Share

Stock News•1 months ago

Avidity Biosciences (NASDAQ:RNA) Stock Price Crosses Below 200-Day Moving Average – Here’s Why

Avidity Biosciences (RNA) fell ~60% below its 200-day moving average of $30.39, trading at $12.29 after hitting an intraday low of $11.61.

RNA

Share

Stock News•2 months ago

Squeeze Watch: 10 Stocks Bears Love to Hate Most Right Now

Short interest is concentrated in a cluster of mid- and large-cap stocks, making them potential squeeze candidates as bearish bets intensify.

CLSK

Share